FDA asks for more tests before it approves Proteus-Otsuka’s sensor-equipped pill
The two companies submitted the system as a new drug application (NDA) with the FDA in September 2015, and the Agency now declined to approve it.
New study uses Fitbit to test if weight loss can prevent breast cancer recurrence
The Breast Cancer Weight Loss (BWEL) study will enroll nearly 3,200 overweight and obese women with early stage breast cancer.
Doctor On Demand to make treating asthma and allergies easier for users
Together with Allergy & Asthma Network, the company will develop a series of services for people with asthma and allergies.
Amazon Echo gets its first healthcare skill – KidsMD
Boston Children's Hospital launches cloud-based education on Amazon Alexa-enabled devices to answer questions around fever and other common symptoms.
FDA clears an online tool for diagnosing ADHD
QbCheck provides unbiased and objective outcome measurements that can be utilized quickly and easily so that professionals are informed to act in ADHD.
AliveCor to launch remote monitoring trial for AFib with Columbia University
The 300-patient randomized trial will test the effect of remote monitoring on atrial fibrillation (AF) using AliveCor's Kardia Mobile device.
FTC’s new tool helps developers determine whether regulations apply to their apps
The tool asks developers a few up questions, and based on these answers, it determines whether federal laws and regulations are relevant to them.
McKesson scores a $139M secure messaging deal from DoD
The solution will improve access to care for DoD beneficiaries, advance care team coordination, and enhance patient engagement.
American Optometric Association: FDA should take action against Opternative
The organization claims that Opternative's smartphone-based eye exams could lead patients to skip eye health exams and endanger their well-being.
WHO unveils the Zika app for healthcare workers
The app is primarily made for healthcare workers and responders, offering technical guidance, a link to WHO's response plan, situation reports and more.